HomeHealth

Health

DaVita Inc. to Participate in Upcoming Investor Conferences

DaVita Inc. to Participate in Upcoming Investor Conferences

November 3, 2026

Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026

Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026

November 3, 2026

Pennant Announces Third Quarter 2026 Earnings Release and Call

Pennant Announces Third Quarter 2026 Earnings Release and Call

November 3, 2026

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences

November 3, 2026

Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC

Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC

November 3, 2026

Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.

Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.

November 3, 2026

ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution

ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution

November 2, 2026

Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results

Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results

November 2, 2026

Eloxx Pharmaceuticals to Present at the 3rd Annual Guggenheim Healthcare Innovation Conference

Eloxx Pharmaceuticals to Present at the 3rd Annual Guggenheim Healthcare Innovation Conference

November 2, 2026

UPDATE — Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

UPDATE — Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

November 2, 2026

1 2 3 … 268 »